CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 944,290 shares at $7.00 ($6,610,030)
- 4 Open-market buy Director bought 18,869 shares at $7.00 ($132,083)
- 8-K Event Bylaws or fiscal year change
- 4 Open-market buy 10% owner bought 827,456 shares at $7.00 ($5,792,192)
- 4 Open-market buy 10% owner bought 1,470,582 shares at $7.00 ($10,294,074)
- 4 Conversion 10% owner acquired 1,432,101 shares (conversion)
- 4 Open-market buy Director bought 1,470,582 shares at $7.00 ($10,294,074)
- 4 Open-market buy 10% owner bought 733,445 shares at $7.00 ($5,134,115)
- 4 Open-market buy Director bought 733,445 shares at $7.00 ($5,134,115)
- 4 Open-market buy Former 10% Owner bought 106,224 shares at $7.00 ($743,568)
- 4 Conversion Former 10% Owner acquired 464,365 shares (conversion)
- 4 Derivatives Options or other derivatives
- 424B4 Offering Prospectus
- CT ORDER Other Confidential Order
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 37 of 39 · 778 filings